Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NBTXR3 |
Trade Name | |
Synonyms | |
Drug Descriptions |
NBTXR3 is a nanoparticle formulation of hafnium oxide, which potentially enhances radiotherapy (PMID: 31296491). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C98280 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ipilimumab + NBTXR3 + Nivolumab | Ipilimumab NBTXR3 Nivolumab | 0 | 1 |
NBTXR3 | NBTXR3 | 0 | 3 |
NBTXR3 + Pembrolizumab | NBTXR3 Pembrolizumab | 0 | 2 |
NBTXR3 + Radiotherapy | NBTXR3 Radiotherapy | 0 | 0 |
NBTXR3 + unspecified PD-1 antibody | NBTXR3 unspecified PD-1 antibody | 0 | 1 |